These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7679244

  • 1. Relation of diurnal variation of ventricular repolarization to ventricular ectopic activity and modification by sotalol.
    Hohnloser SH, Zabel M, Just H, Raeder EA.
    Am J Cardiol; 1993 Feb 15; 71(5):475-8. PubMed ID: 7679244
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of sotalol in patients with complex ventricular arrhythmias.
    Hohnloser SH, Zabel M, van de Loo A, Klingenheben T, Just H.
    Int J Cardiol; 1992 Dec 15; 37(3):283-91. PubMed ID: 1281807
    [Abstract] [Full Text] [Related]

  • 3. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G, Sen L, Sager P, Uppal P, Singh BN.
    Am J Cardiol; 1994 Nov 01; 74(9):896-900. PubMed ID: 7526675
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.
    Frommeyer G, Weller J, Ellermann C, Leitz P, Kochhäuser S, Lange PS, Dechering DG, Eckardt L.
    Cardiovasc Toxicol; 2019 Apr 01; 19(2):129-135. PubMed ID: 30238354
    [Abstract] [Full Text] [Related]

  • 6. Interaction of acute ventricular dilatation and d-sotalol during sustained reentrant ventricular tachycardia around a fixed obstacle.
    Reiter MJ, Zetelaki Z, Kirchhof CJ, Boersma L, Allessie MA.
    Circulation; 1994 Jan 01; 89(1):423-31. PubMed ID: 7506639
    [Abstract] [Full Text] [Related]

  • 7. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR, Gray RA, Karasik P, Moore HJ, Singh SN.
    Europace; 2014 Nov 01; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [Abstract] [Full Text] [Related]

  • 8. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
    Aliot E, Sadoul N, De Chillou C.
    Eur Heart J; 1993 Nov 01; 14 Suppl H():74-7. PubMed ID: 7904940
    [Abstract] [Full Text] [Related]

  • 9. Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings.
    Shimizu W, Kurita T, Suyama K, Aihara N, Kamakura S, Shimomura K.
    Am J Cardiol; 1996 May 01; 77(11):1004-8. PubMed ID: 8644624
    [Abstract] [Full Text] [Related]

  • 10. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T, Lehmann C, Pfammatter JP, Kallfelz HC.
    Z Kardiol; 1994 Dec 01; 83(12):891-7. PubMed ID: 7531374
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Delayed ventricular repolarization as an anti-arrhythmic principle.
    Vaughan Williams EM.
    Eur Heart J; 1985 Nov 01; 6 Suppl D():145-9. PubMed ID: 2417849
    [Abstract] [Full Text] [Related]

  • 13. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A, Shenasa M, Chen X, Wichter T, Breithardt G, Borggrefe M.
    Am J Cardiol; 1994 Feb 15; 73(5):357-60. PubMed ID: 7509121
    [Abstract] [Full Text] [Related]

  • 14. Three Different Types of Tachyarrhythmia and QT Prolongation in a Suicide Attempt.
    Sahashi Y, Naruse G, Okura H.
    Circulation; 2019 Jun 04; 139(23):2703-2706. PubMed ID: 31158001
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between the effective refractory period and activation-recovery interval calculated from the intracardiac unipolar electrogram of humans with and without dl-sotalol treatment.
    Chinushi M, Tagawa M, Kasai H, Washizuka T, Abe A, Furushima H, Aizawa Y.
    Jpn Circ J; 2001 Aug 04; 65(8):702-6. PubMed ID: 11502045
    [Abstract] [Full Text] [Related]

  • 16. Autonomic effects of antiarrhythmic drugs and their importance.
    Lombardi F, Torzillo D, Sandrone G, Dalla Vecchia L, Cappiello E.
    Eur Heart J; 1992 Nov 04; 13 Suppl F():38-43. PubMed ID: 1282464
    [No Abstract] [Full Text] [Related]

  • 17. Sotalol for refractory sustained ventricular tachycardia and nonfatal cardiac arrest.
    Singh SN, Cohen A, Chen YW, Wish M, Thoben-O'Grady L, Peralba J, Gottdiener J, Fletcher RD.
    Am J Cardiol; 1988 Sep 01; 62(7):399-402. PubMed ID: 2458026
    [Abstract] [Full Text] [Related]

  • 18. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T, Hohnloser SH.
    Z Kardiol; 1994 Apr 01; 83(4):293-8. PubMed ID: 8023542
    [Abstract] [Full Text] [Related]

  • 19. Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes.
    Bonatti V, Rolli A, Botti G.
    Eur Heart J; 1985 Nov 01; 6 Suppl D():131-43. PubMed ID: 2417848
    [Abstract] [Full Text] [Related]

  • 20. Pathogenesis, recognition, and management of common cardiac arrhythmias. Part I: Ventricular premature beats and tachyarrhythmias.
    Alpert MA, Mukerji V, Bikkina M, Concannon MD, Hashimi MW.
    South Med J; 1995 Jan 01; 88(1):1-21. PubMed ID: 7529434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.